In May 2022, Dr. Trzeciakiewicz joined the Translational Neuroscience Department and the Kanaan laboratory as a Research Associate. For the past decade, Dr. Trzeciakiewicz has been researching many facets of the tau protein. As an undergraduate at Oakland University, she investigated in vitro tau protein misfolding and aggregation. At the University of North Carolina at Chapel Hill, her dissertation work helped uncover how tau post-translational modifications (PTMs) regulate its function, track with disease progression, and ultimately contribute to tauopathies (i.e. Alzheimer’s disease and related dementias). As a NIH/NINDS Training in Clinical and Basic Neuroscience T32 Fellow at the University of Michigan, Dr. Trzeciakiewicz explored the malfunction of tau protein quality control. The goal of her current work is to identify tau-interacting proteins and tau-PTM signatures for the different tau-mediated neurodegenerative disorders.